Linde Peter 4

4 · Morphic Holding, Inc. · Filed Mar 18, 2020

Form 4

Period: 2020-03-16

Chief Medical Officer

Transactions

Award
Restricted Stock Unit (RSU)
2020-03-16+45,460→ 45,460 total
Exp: 2024-03-16→ Common Stock (45,460 underlying)
Award
Stock Option (right to buy Common Stock)
2020-03-16+181,840→ 181,840 total
Exercise: $10.84Exp: 2030-03-15→ Common Stock (181,840 underlying)
Award
Restricted Stock Unit (RSU)
2020-03-16+20,756→ 20,756 total
Exp: 2021-09-16→ Common Stock (20,756 underlying)

Footnotes (4)

[F1]The option vests as to 1/4 of the total shares on March 16, 2021, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on March 16, 2024, subject to the reporting person's provision of service to the Issuer on each vesting date.
[F2]Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
[F3]The RSU vests 25% on each of March 16, 2021, March 16, 2022, March 16, 2023 and March 16, 2024, subject to the reporting person's provision of service to the Issuer on each vesting date.
[F4]The RSU vests 50% on March 16, 2021 and the remaining 50% vests on September 16, 2021, subject to the reporting person's provision of service to the Issuer on each vesting date.

Documents

1 file